Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001386795.1(DTNA):c.17G>C(p.Gly6Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,134 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
DTNA (HGNC:3057): (dystrobrevin alpha) The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The Gly6Ala variant in DTNA has not been previously reported in any other famili es with cardiomyopathy or in large population studies. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. Additional information is needed to fully assess the clin ical significance of the Gly6Ala variant. -
Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);Loss of glycosylation at S5 (P = 0.0524);